Percutaneous ethanol injection for hepatocellular carcinoma: 20-year outcome and prognostic factors
β Scribed by Shuichiro Shiina; Ryosuke Tateishi; Masatoshi Imamura; Takuma Teratani; Yukihiro Koike; Shinpei Sato; Shuntaro Obi; Fumihiko Kanai; Naoya Kato; Haruhiko Yoshida; Masao Omata; Kazuhiko Koike
- Book ID
- 115293997
- Publisher
- John Wiley and Sons
- Year
- 2012
- Tongue
- English
- Weight
- 332 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0106-9543
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: The objective of this study was to identify clinical, biochemical, ultrasound, and/or pathologic parameters capable of predicting survival in a cohort of patients with well compensated cirrhosis and small hepatocellular carcinoma (hcc) who were treated with percutaneous ethanol injec
## BACKGROUND. Percutaneous ethanol injection therapy has been used widely for small hepatocellular carcinoma. This study was undertaken to determine factors predictive of local recurrence or new nodular recurrence in patients with small hepatocellular carcinoma treated with percutaneous ethanol in
## Background: Percutaneous ethanol injection (pei) has been used in the far east for treating small, unresectable hepatocellular carcinoma (hcc). to clarify when treatment with pei may be best indicated for western patients with hcc, the authors performed a retrospective analysis of the clinicopat